載入...
Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
BACKGROUND: Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. CASE PRESENTATION: We report a female patient with disseminated melanoma metastases. Two days after the first dosage of combined immunotherapy using the cytotoxic T lymphocyte antigen-4 (CT...
Na minha lista:
| 發表在: | J Immunother Cancer |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6208032/ https://ncbi.nlm.nih.gov/pubmed/30376886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0430-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|